-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/dot-plots-methods.pdf
October 01, 2021 - Dot plot for dichotomous outcomes, statins versus placebo or no statin ........................ 3
Figure … focused on
dichotomous outcomes; for the pilot we used pooled data for statins versus placebo or no statin … Dot plot for dichotomous outcomes, statins versus placebo or no statin
Abbreviations: AE = adverse
-
cds.ahrq.gov/cdsconnect/artifact/statin-use-primary-prevention-cvd-adults-clinician-facing-cds-intervention
July 10, 2017 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/cdsconnect/source/centers-medicare-and-medicaid-services-cms347v7-statin-therapy-prevention-and
April 07, 2025 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_international_king.ppt
January 01, 2005 - What do we know about how evidence of harm and benefit is communicated in other countries?
What do we know about how evidence of harm and benefit is communicated in other countries?
Valerie King MD, MPH and David Hickam MD, MPH
John M. Eisenberg Clinical Decisions and Communications Science Center
Oregon Health &…
-
www.ahrq.gov/patient-safety/settings/long-term-care/resource/hcbs/medicaidmgmt/exh7-4.html
October 01, 2014 - members with diabetes with:
Most recent LDL-C <100 mg/dl or
LDL-C =100 mg/dl and on highest dose statin … or
Statin started or statin increased within 6 mos of last value
Case Data.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND__0250_05-20-2010.pdf
January 01, 2010 - Effective Health Care
Topic Number(s): 0268a-b-c
Document Completion Date: 02-25-11
1
Results of Topic Selection Process & Next Steps
Treatment of atrial fibrillation (AF) and stroke prevention in AF will go forward for refinement as
systematic reviews. Primary prevention of AF will not go f…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/uPbfDukSXmFDWq8FDwTgKj
recommendations on many factors related to CVD prevention, including screening for high blood pressure,
statin
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_disposition-comments.pdf
January 07, 2016 - Thank you for your comment
49 Technical
Expert #3
Results Results: Statin section: Although the … section you report the statin doses used in trials but don't tell me the drug. … A new analysis has been added to the statin
section comparing statin plus NAC v NAC
alone. … As I understand, statin trials were conducted in a specific population. … The included studies are on subjects who are
statin naive.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/observational-research-scores_research.pdf
May 01, 2012 - The rarity of
rhabdomyolysis (estimated incidence 0.4-6.0 per 10,000 person-years among statin users … However, an observational study of rhabdomyolysis among rosuvastatin and other statin users is
also … Since LDL level is a primary indication for statin therapy and higher
LDL levels are anticipated to … Table 4 shows the effect of matching on
the statin statistics. … A propensity score−matched cohort study of the effect of
statin, mainly fluvastatin, on the occurrence
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
January 01, 2012 - No statin trials reported clinical outcomes data for
patients with albuminuria. … - In RCTs that compared high- versus low-dose
treatment (ARB, statin), strict versus standard
control … creatinine clearance, screening
such patients for impaired eGFR could lead to early
initiation of statin … Statin vs. statin (high
vs. low dose)
2 trials; 4,793
patients
Mortality: low
ESRD: insufficient … Effectiveness of statin
therapy in adults with coronary heart disease.
-
psnet.ahrq.gov/node/73063/psn-pdf
March 24, 2021 - measurement-matters-changing-penalty-calculations-under-hospital-acquired-condition-reduction
https://psnet.ahrq.gov/issue/errors-electronic-health-record-based-data-query-statin-prescriptions-patients-coronary
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Pilot%20Report_Final_0.docx
March 01, 2018 - and technical work efforts, and findings of the CDS Connect pilot of a newly developed CDS artifact, Statin … to interview clinicians regarding their workflow related to patient assessment in consideration of statin … In regard to the USPSTF Statin Use recommendation statement related to statin therapy for the treatment … The CDS Connect pilot CDS, Statin Use for the Primary Prevention of CVD in Adults, based on a USPSTF … additional investment in maintaining and enhancing CDS built with the underlying USPSTF guidance on statin
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/tools-and-materials/skills-qi-report.pdf
June 02, 2025 - Support Provided:
Quality Improvement (QI)
Stage:
Practice Response:
Plan
☐ Aspirin
☐ Statin … Plan:
Quality Improvement QI Stage:
Practice Response:
Support ProvidedRow1:
Aspirin_2: Off
Statin
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/nephropathy-contrast-induced_clinician.pdf
August 01, 2016 - e One study included in this meta-analysis compared a statin + sodium
bicarbonate + IV saline versus
-
cds.ahrq.gov/sites/default/files/workgroups/246/jul-2017-cholesterol-wg-notes.docx
January 01, 2017 - Updates on the Pilot and Artifacts
CAMH provided an update on the status of the USPSTF Statin Use artifact … Pilot
The USPSTF Statin Use artifact was tested for one week and several of the components of the artifact … Statin medications: The CAMH team used Quality Insights of Pennsylvania’s value sets, which included
-
digital.ahrq.gov/sites/default/files/docs/citation/r18hs022767-jean-jacques-final-report-2014.pdf
January 01, 2014 - The rate of statin prescribing for patients with FRS ≥ 10% did not change
in either the low or high … • The clinical treatment outcome for CVD prevention, the rate of statin prescribing for those with … The CVS prevention CDS use
outcome, the rate of statin prescribing for patients with FRS ≥ 10%, did … 245/248 (99) 346/348 (99) 115/117 158/164 0 p=0.7
for patients with persistent asthma (98) (96)
Statin … CHC A High Intensity Support
CHC C Low Intensity Support
CHC C High Intensity Support
Statin
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/reporting-instructions-baseline-sw.pdf
June 02, 2025 - diabetes with a fasting
or direct LDL-C level of 70-189 mg/dL; who were prescribed or are already on
statin … dl=0
https://www.dropbox.com/s/lv3var6pov8ztg1/Statin Therapy Measure Narrative v2.docx?
-
www.ahrq.gov/evidencenow/heart-health/cholesterol/algorithm.html
September 01, 2018 - Cholesterol Management Treatment Algorithm
Resource title: Heart Health NOW! Lipid Algorithm
Resource description: This decision tree summarizes recommendations for prescribing statins in primary and secondary treatment of cardiovascular disease.
Document author(s)/institution of origin: University of No…
-
cds.ahrq.gov/sites/default/files/cds/artifact/81/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%20Risk_Final_0.docx
October 01, 2017 - the expected benefit from a preventive intervention (i.e., aspirin, blood pressure-lowering therapy, statin … preventive interventions, including smoking cessation, aspirin therapy, blood pressure control, and statin … a year ago, and making use of the Shared Decision Making tool, decided to stop smoking and to begin statin … codes from statin therapy value sets created in support of PQRS#438 Statin Therapy for the Prevention … "preventive therapies"
One or more of the following: smoking cessation, hypertension treatment, statin
-
www.ahrq.gov/evidencenow/heart-health/cholesterol/outreach.html
September 01, 2018 - Automated Outreach & Adherence to Cholesterol-Lowering Medication
Resource title: Automated Outreach to Increase Primary Adherence to Cholesterol-Lowering Medications .
Resource description: This journal article summarizes findings from a randomized controlled trial that evaluated an automated system for im…